BBBarbara S. Beckman

Barbara S. Beckman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Barbara S. Beckman has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of environmental estrogens on tumor necrosis factor α-mediated apoptosis in MCF-7 cells

    by M E Burow, Y Tang, B M Collins-Burow, S Krajewski, J C Reed, J A McLachlan, B S Beckman

    Environmental estrogens represent a class of compounds which have been shown to mimic the effects or activity of the naturally occurring ovarian hormone 17β-estradiol. Given the role of 17β-estradiol in cell survival in a number of systems, we wished to determine if environmental estrogens protect MCF-7 cells from apoptosis. Here we demonstrate that the organochlorine pesticides o , p ′ DDT and alachlor, like 17β-estradiol, have the ability to suppress tumor necrosis factor α (TNF)-induced apoptosis in estrogen receptor (ER)-positive MCF-7 breast carcinoma cells. These compounds, however, did not affect TNF-induced apoptosis of the ER-negative MDA-MB-231 cell line. The ability of these compounds to suppress apoptosis in MCF-7 cells was correlated with an ER-dependent increase in Bcl-2 expression. Taken together these results demonstrate that estrogenic organochlorine pesticides like o , p ′ DDT and alachlor may partially mimic the primary endogenous estrogen, 17β-estradiol, and function to suppress apoptosis in ER-responsive cells.


  • Changes in redox affect the activity of erythropoietin RNA binding protein

    by Isaac J. Rondon, Aline B. Scandurro, Russell B. Wilson, Barbara S. Beckman

    We have previously identified a cytosolic protein, erythropoietin RNA binding protein (ERBP), which is up-regulated in certain tissues in response to hypoxia. To further characterize the interaction of ERBP and erythropoietin (EPO) mRNA, we have examined the role of reduction-oxidation in the EPO mRNA binding mechanism of ERBP isolated from human hepatoma cells (Hep3B). Reducing agents dithiothreitol (DTT) and 2-mercaptoethanol (2-ME) increased ERBP binding activity in a concentration-dependent manner, whereas the oxidizing agent, diamide, abolished ERBP binding activity. In addition, treatment of Hep3B cell lysates with the irreversible sulfhydryl alkylating agent N -ethylmaleimide resulted in inhibition of the EPO mRNA-ERBP complex. Taken together, these findings suggest that sulfhydryl groups may play a role in vivo in the regulation of EPO production through the modulation of ERBP binding activity.